Henry Ji | Source | Chairman, President, and CEO at Sorrento Therapeutics
Henry Ji
Chairman, President, and CEO at Sorrento Therapeutics
Link:
Bio
Edit
Chairman, President, and CEO of Sorrento Therapeutics
Employment
Sign up to view all
-
Sorrento Therapeutics (https://sorrentotherapeutics.com/)
Chairman, President, and CEO
Media
Sign up to view all
-
Lee’s Pharmaceutical Announces Its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Breakthrough Therapy Designation in China for the Treatment of Recurrent or Metastatic Cervical Cancer
Socazolimab is an anti-PD-L1 antibody licensed from Sorrento for the Greater China Territory by Lee’s Pharma.China National Medical Products Administration...
Article
Recent Quotes
Sign up to view all
-
We at Sorrento are happy with the collaboration with our colleagues at Lee’s Pharma and are satisfied with the clinical advance of our first therapeutic antibody partnership in socazolimab. We currently plan to expand our partnership with Lee’s Pharma and are in discussions regarding the co-development of additional therapeutic antibodies from Sorrento to treat hematologic and solid tumors.
